Kazakhstan and Russia Reach Agreement on New Coronavirus Vaccine

On August 26. According to the news from the Russian Satellite News Agency and TASS News Agency on the 26th, Kazakhstan and Russia have reached an agreement on the new coronavirus vaccine, and Kazakhstan will obtain a guaranteed supply of vaccine after the test.

According to a report on the Kazakhstan government website, the Russian Direct Investment Fund and the Kazakhstan SK Pharmaceutical Company have signed an understanding agreement, promising to obtain a sufficient amount of the new crown vaccine 'Sputnik-V' supply after the test is over. Kazakhstan is ready to invest in the establishment of a national epidemiology and microbiology research center. Kazakhs can receive free and voluntary vaccination.

The Russian Ministry of Health has authorized the Gamaleya National Research Center for Epidemiology and Microbiology on the 24th to transfer the trial after registration of the new coronavirus vaccine. The news said, 'There will be 40,000 volunteers over 18 years of age participating in the trial. Every volunteer must be observed for half a year after vaccination.'

According to earlier reports by Russian media, the Russian Ministry of Health registered the world's first vaccine for the prevention of new coronavirus infection on August 11, which was jointly developed by the Gamaleya National Research Center for Epidemiology and Microbiology and the Russian Direct Investment Fund. The vaccine was named 'Sputnik-V'.